Linezolid (IV and PO)

DRUG2 trials

Sponsors

MicuRx, Alexandria University

Conditions

Diabetic Foot InfectionKidney Disease

Phase 3

Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)

RecruitingNCT05369052

MicuRxDiabetic Foot Infection

Start: 2022-05-03End: 2026-06-30Target: 865Updated: 2025-09-10

Phase 4

Optimizing Linezolid Dosing in Patients With Advanced Renal Impairment: a Therapeutic Drug Monitoring-based Evaluation

Not yet recruitingNCT07138521

Alexandria UniversityKidney Disease

Start: 2025-10-15End: 2026-05-15Target: 50Updated: 2025-08-24